Related references
Note: Only part of the references are listed.Antifungal Activity of Colistin against Mucorales Species In Vitro and in a Murine Model of Rhizopus oryzae Pulmonary Infection
Ronen Ben-Ami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Contribution of Candida albicans Cell Wall Components to Recognition by and Escape from Murine Macrophages
C. G. J. McKenzie et al.
INFECTION AND IMMUNITY (2010)
Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Chitin Is a Size-Dependent Regulator of Macrophage TNF and IL-10 Production
Carla A. Da Silva et al.
JOURNAL OF IMMUNOLOGY (2009)
Fungal LysM effectors: extinguishers of host immunity?
Ronnie de Jonge et al.
TRENDS IN MICROBIOLOGY (2009)
Functional analysis of Candida albicans GPI-anchored proteins: Roles in cell wall integrity and caspofungin sensitivity
Armel Plaine et al.
FUNGAL GENETICS AND BIOLOGY (2008)
Stimulation of chitin synthesis rescues Candida albicans from echinocandins
Louise A. Walker et al.
PLOS PATHOGENS (2008)
Resistance to echinocandin-class antifungal drugs
David S. Perlin
DRUG RESISTANCE UPDATES (2007)
The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans
Carol A. Munro et al.
MOLECULAR MICROBIOLOGY (2007)
Escape of Candida from caspofungin inhibition at concentrations above the MIC (Paradoxical effect) accomplished by increased cell wall chitin;: Evidence for β-1,6-glucan synthesis inhibition by caspofungin
David A. Stevens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility
Santosh Katiyar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin
CD Miller et al.
PHARMACOTHERAPY (2006)
A drug-sensitive genetic network masks fungi from the immune system
Robert T. Wheeler et al.
PLOS PATHOGENS (2006)
Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis
M Laverdière et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species
G Chamilos et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
High-throughput and sensitive assay to measure yeast cell growth: a bench protocol for testing genotoxic agents
Martin Toussaint et al.
NATURE PROTOCOLS (2006)
Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1
Sergey V. Balashov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: Relationship of MIC to treatment outcome
N Kartsonis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp isolates
S Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Mice with disseminated candidiasis die of progressive sepsis
B Spellberg et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Evolution of antifungal-drug resistance: Mechanisms and pathogen fitness
JB Anderson
NATURE REVIEWS MICROBIOLOGY (2005)
Release from quorum-sensing molecules triggers hyphal formation during Candida albicans resumption of growth
B Enjalbert et al.
EUKARYOTIC CELL (2005)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Multilocus sequence typing is a reliable alternative method to DNA fingerprinting for discrimination among strains of Candida albicans
JC Robles et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates
PD Rogers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Population genomics of drug resistance in Candida albicans
LE Cowen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans
LE Cowen et al.
JOURNAL OF BACTERIOLOGY (2001)
Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants
J DeRisi et al.
FEBS LETTERS (2000)
Share Paper
